Antony C. Mattessich, President & CEO at OCULAR THERAPEUTIX, INC (OCUL), bought 20,000 shares at $5.95 ($119K) on 2018-08-20, disclosed to the SEC on 2018-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCUL | BUY | 2023-09-05 | $25K | — | Filing → |
| OCUL | SELL | 2023-02-08 | $167K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |